Purpose The standard of care for differentiated thyroid carcinoma (DTC) includes surgery,
risk-adapted postoperative radioiodine therapy (RaIT), individualized thyroid hormone …

Simple Summary This year marks the 80th commemoration of the first time that radio-iodide
treatment (RAI) was used. RAI is one of the most effective targeted internal radiation …

Supramolecular organic frameworks (SOFs) and covalent organic frameworks (COFs) have
been the focus of researchers for a long time because of their regular periodic structure and …

Simple Summary Radioactive iodine treatment is the oldest targeted therapy for
differentiated thyroid cancer. It can be used for normal thyroid remnant ablation (in order to …

Background Papillary thyroid cancer (PTC) is the most frequent endocrine tumor.
Radioiodine (RAI) treatment is highly effective in these tumors, but up to 60% of metastatic …

Abstract Objective According to the 2015 American Thyroid Association (ATA) guidelines,
thyroid ablation by iodine-131 (I-131) therapy is absolutely recommended only in patients …

Purpose Distant metastases (DM) from DTC occur in 5–25% of cases and are correlated to
lower survival; the prognostic significance of the temporal onset of DM is unclear. Our aim …

This study was conducted to investigate the effects of thyroid hormone withdrawal (THW)
and recombinant human thyroid-stimulating hormone (rhTSH) administration on renal …

Purpose Papillary thyroid carcinoma (PTC) is among the most curable cancer types. Even
though uncommon, some patients present distant metastatic disease at diagnosis or during …

Background In some patients with metastatic differentiated thyroid cancer, even if they had
substantial of radioactive iodine (RAI) uptake, the RAI therapy response was poor. We …